LRG1, a novel serum biomarker for iMCD disease activity
Abstract Idiopathic multicentric Castleman disease (iMCD) is a rare lymphoproliferative disorder characterized by systematic inflammatory symptoms and multiorgan dysfunction caused by a cytokine storm. The current assessment of treatment response in iMCD lack sensitivity due to the heterogeneity of...
Saved in:
| Main Authors: | Miao-yan Zhang, Zi-han Yang, Yu-chong Qiu, Yu-han Gao, Si-yuan Li, Yue Dang, Lu Zhang, Jian Li |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2025-04-01
|
| Series: | Biomarker Research |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s40364-025-00767-1 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
LRG1 Alters Pericyte Phenotype and Compromises Vascular Maturation
by: Alexandra E. Hoeh, et al.
Published: (2025-04-01) -
Atypical clinical presentation associated with Castleman disease: a case report and review of the literature
by: Weiwei Hu, et al.
Published: (2025-08-01) -
Prognostic value of serum C-reactive protein in idiopathic multicentric Castleman disease and construction of a prognostic model for patients
by: Zhixiang Lei, et al.
Published: (2025-04-01) -
Efficient diagnosis for endoscopic remission in Crohn’s diseases by the combination of three non-invasive markers
by: Kensuke Takei, et al.
Published: (2025-05-01) -
Leucine-rich alpha-2 glycoprotein is useful in predicting clinical relapse in patients with Crohn’s disease during biological remission
by: Naohiro Nakamura, et al.
Published: (2025-04-01)